Cargando…
Blood borne transit of CJD from brain to gut at early stages of infection
BACKGROUND: In Creutzfeldt-Jakob disease (CJD) and other related transmissible spongiform encephalopathies it is critical to understand the various pathways by which the infectious agent spreads to different organs. METHODS: We injected a CJD agent into mice, either intracerebrally (ic) or intraperi...
Autores principales: | , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2001
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC59894/ https://www.ncbi.nlm.nih.gov/pubmed/11716790 http://dx.doi.org/10.1186/1471-2334-1-20 |
_version_ | 1782120109717848064 |
---|---|
author | Radebold, Klaus Chernyak, Mark Martin, Daniel Manuelidis, Laura |
author_facet | Radebold, Klaus Chernyak, Mark Martin, Daniel Manuelidis, Laura |
author_sort | Radebold, Klaus |
collection | PubMed |
description | BACKGROUND: In Creutzfeldt-Jakob disease (CJD) and other related transmissible spongiform encephalopathies it is critical to understand the various pathways by which the infectious agent spreads to different organs. METHODS: We injected a CJD agent into mice, either intracerebrally (ic) or intraperitoneally (ip) and monitored the progressive appearance of abnormal PrP in peripheral tissues over time. RESULTS: Abnormal PrP was detected in lymphoreticular tissues of the gastrointestinal tract as early as 28 to 32 days after infection by both routes. This change persisted until the terminal stages of disease. In contrast, abnormal PrP was not detected in brain or spinal cord until 80 to 120 days after ic inoculation, or until 170 days after ip inoculation. CONCLUSIONS: Brain lacks significant lymphatic drainage, and has little infectivity before 40 days, even after ic inoculation. Thus the infectious inoculum must spread to the gut by a vascular route, a direction opposite to that generally assumed. This interpretation is consistent with previous studies demonstrating white blood cell infectivity as well as perivascular PrP accumulations in CJD. Notably, enteric infection at early as well as later stages of disease, and regardless of the route of agent entry, implicates potential environmental spread by fecal matter. |
format | Text |
id | pubmed-59894 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2001 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-598942001-11-21 Blood borne transit of CJD from brain to gut at early stages of infection Radebold, Klaus Chernyak, Mark Martin, Daniel Manuelidis, Laura BMC Infect Dis Research Article BACKGROUND: In Creutzfeldt-Jakob disease (CJD) and other related transmissible spongiform encephalopathies it is critical to understand the various pathways by which the infectious agent spreads to different organs. METHODS: We injected a CJD agent into mice, either intracerebrally (ic) or intraperitoneally (ip) and monitored the progressive appearance of abnormal PrP in peripheral tissues over time. RESULTS: Abnormal PrP was detected in lymphoreticular tissues of the gastrointestinal tract as early as 28 to 32 days after infection by both routes. This change persisted until the terminal stages of disease. In contrast, abnormal PrP was not detected in brain or spinal cord until 80 to 120 days after ic inoculation, or until 170 days after ip inoculation. CONCLUSIONS: Brain lacks significant lymphatic drainage, and has little infectivity before 40 days, even after ic inoculation. Thus the infectious inoculum must spread to the gut by a vascular route, a direction opposite to that generally assumed. This interpretation is consistent with previous studies demonstrating white blood cell infectivity as well as perivascular PrP accumulations in CJD. Notably, enteric infection at early as well as later stages of disease, and regardless of the route of agent entry, implicates potential environmental spread by fecal matter. BioMed Central 2001-10-25 /pmc/articles/PMC59894/ /pubmed/11716790 http://dx.doi.org/10.1186/1471-2334-1-20 Text en Copyright © 2001 Radebold et al; licensee BioMed Central Ltd. This is an Open Access article: verbatim copying and redistribution of this article are permitted in all media for any purpose, provided this notice is preserved along with the article's original URL. |
spellingShingle | Research Article Radebold, Klaus Chernyak, Mark Martin, Daniel Manuelidis, Laura Blood borne transit of CJD from brain to gut at early stages of infection |
title | Blood borne transit of CJD from brain to gut at early stages of infection |
title_full | Blood borne transit of CJD from brain to gut at early stages of infection |
title_fullStr | Blood borne transit of CJD from brain to gut at early stages of infection |
title_full_unstemmed | Blood borne transit of CJD from brain to gut at early stages of infection |
title_short | Blood borne transit of CJD from brain to gut at early stages of infection |
title_sort | blood borne transit of cjd from brain to gut at early stages of infection |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC59894/ https://www.ncbi.nlm.nih.gov/pubmed/11716790 http://dx.doi.org/10.1186/1471-2334-1-20 |
work_keys_str_mv | AT radeboldklaus bloodbornetransitofcjdfrombraintogutatearlystagesofinfection AT chernyakmark bloodbornetransitofcjdfrombraintogutatearlystagesofinfection AT martindaniel bloodbornetransitofcjdfrombraintogutatearlystagesofinfection AT manuelidislaura bloodbornetransitofcjdfrombraintogutatearlystagesofinfection |